ArticleEClinicalMedicine2023

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials.

Subodh Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.